|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Luo H, Zhang NQ, Huang J, Zhang X, Feng
XL, Pan ZZ, Chen YM, Fang YJ and Zhang CX: Dietary intakes of
different forms and sources of iron and colorectal cancer risk: A
case-control study in China. Br J Nutr. 121:735–747. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Inadomi J and Jung B: Colorectal
cancer-recent advances and future challenges. Gastroenterology.
158:289–290. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aloia L, Demajo S and Di Croce L: ZRF1: A
novel epigenetic regulator of stem cell identity and cancer. Cell
Cycle. 14:510–515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Imamura T, Komatsu S, Ichikawa D, Miyamae
M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi
H, et al: Overexpression of ZRF1 is related to tumor malignant
potential and a poor outcome of gastric carcinoma. Carcinogenesis.
39:263–271. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Demajo S, Uribesalgo I, Gutiérrez A,
Ballaré C, Capdevila S, Roth M, Zuber J, Martín-Caballero J and Di
Croce L: ZRF1 controls the retinoic acid pathway and regulates
leukemogenic potential in acute myeloid leukemia. Oncogene.
33:5501–5510. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Waldvogel HJ, Curtis MA, Baer K, Rees MI
and Faull RL: Immunohistochemical staining of post-mortem adult
human brain sections. Nat Protoc. 1:2719–2732. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Varghese F, Bukhari AB, Malhotra R and De
A: IHC Profiler: An open source plugin for the quantitative
evaluation and automated scoring of immunohistochemistry images of
human tissue samples. PLoS One. 9:e968012014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang Y, Lin L, Shen Z, Li Y, Cao H, Peng
L, Qiu Y, Cheng X, Meng M, Lu D, et al: CEBPG promotes esophageal
squamous cell carcinoma progression by enhancing PI3K-AKT
signaling. Am J Cancer Res. 10:3328–3344. 2020.PubMed/NCBI
|
|
12
|
Liu Y, Marin A, Ejlerskov P, Rasmussen LM,
Prinz M and Issazadeh-Navikas S: Neuronal IFN-beta-induced
PI3K/Akt-FoxA1 signalling is essential for generation of FoxA1+Treg
cells. Nat Commun. 8:147092017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu P, Begley M, Michowski W, Inuzuka H,
Ginzberg M, Gao D, Tsou P, Gan W, Papa A, Kim BM, et al:
Cell-cycle-regulated activation of Akt kinase by phosphorylation at
its carboxyl terminus. Nature. 508:541–545. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ribeiro JD, Morey L, Mas A, Gutierrez A,
Luis NM, Mejetta S, Richly H, Benitah SA, Keyes WM and Di Croce L:
ZRF1 controls oncogene-induced senescence through the INK4-ARF
locus. Oncogene. 32:2161–2168. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Katsoulas A, Rachid Z, McNamee JP,
Williams C and Jean-Claude BJ: Combi-targeting concept: An
optimized single-molecule dual-targeting model for the treatment of
chronic myelogenous leukemia. Mol Cancer Ther. 7:1033–1043. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dyachenko L, Havrysh K, Lytovchenko A,
Dosenko I, Antoniuk S, Filonenko V and Kiyamova R: Autoantibody
response to ZRF1 and KRR1 SEREX antigens in patients with breast
tumors of different histological types and grades. Dis Markers.
2016:51287202016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Z, Li J, Huang Y, Peng W, Qian W, Gu
J, Wang Q, Hu T, Ji D, Ji B, et al: Upregulated miR-1258 regulates
cell cycle and inhibits cell proliferation by directly targeting
E2F8 in CRC. Cell Prolif. 51:e125052018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu X, Zhou Y, Ning YE, Gu H, Tong Y and
Wang N: MiR-195-5p inhibits malignant progression of cervical
cancer by targeting YAP1. OncoTargets Ther. 13:931–944. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zierau O, Helle J, Schadyew S, Morgenroth
Y, Bentler M, Hennig A, Chittur S, Tenniswood M and Kretzschmar G:
Role of miR-203 in estrogen receptor-mediated signaling in the rat
uterus and endometrial carcinoma. J Cell Biochem. 119:5359–5372.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen M, Zhou M, Fu Y, Li J and Wang Z:
Effects of miR-672 on the angiogenesis of adipose-derived
mesenchymal stem cells during bone regeneration. Stem Cell Res
Ther. 12:852021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ahmad N, Kushwaha P, Karvande A, Tripathi
AK, Kothari P, Adhikary S, Khedgikar V, Mishra VK and Trivedi R:
MicroRNA-672-5p identified during weaning reverses osteopenia and
sarcopenia in ovariectomized mice. Mol Ther Nucleic Acids.
14:536–549. 2019. View Article : Google Scholar : PubMed/NCBI
|
